CervoMed (CRVO) Return on Invested Capital (2016 - 2018)
CervoMed (CRVO) posted Return on Invested Capital of 0.22% for Q4 2018, down 108.74% sequentially from 0.11% in Q3 2018.
CervoMed (CRVO) Return on Invested Capital (2016 - 2018) Analysis & Trends
CervoMed has reported Return on Invested Capital for 2 years, with the latest figure at 0.22% in Q4 2018.
- Quarterly Return on Invested Capital changed N/A year-over-year to 0.22% in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.22% (changed N/A YoY) and the FY2017 annual result came in at 0.05%, up 10.0% from the prior year.
- Return on Invested Capital slipped to 0.22% in Q4 2018 per CRVO's latest filing, from 0.11% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.01% in Q2 2018 and troughed at 0.22% in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -0.22% |
| Sep 30, 2018 | -0.11% |
| Jun 30, 2018 | 0.01% |
| Dec 31, 2016 | -0.05% |
| Sep 30, 2016 | -0.11% |